Dizon, Don S.

Digitizing clinical trials

Inan, O. T., Tenaerts, P., Prindiville, S. A., Reynolds, H. R., Dizon, D. S., Cooper-Arnold, K., Turakhia, M., Pletcher, M. J., Preston, K. L., Krumholz, H. M., et al. (2020) · npj Digital Medicine

Mobile Health and mHealth ApplicationsStatistical Methods in Clinical Trials

Cited by 329

Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update

Andersen, B. L., Lacchetti, C., Ashing, K., Berek, J. S., Berman, B. S., Bolte, S., Dizon, D. S., Given, B., Nekhlyudov, L., Pirl, W., et al. (2023) · Journal of Clinical Oncology

Cancer survivorship and careChildhood Cancer Survivors' Quality of Life

Cited by 318

Practical guidance: the use of social media in oncology practice

Dizon, D. S., Graham, D., Thompson, M. A., Johnson, L. J., Johnston, C., Fisch, M. J., & Miller, R. (2012) · Journal of Oncology Practice

Social Media in Health EducationHealth Literacy and Information Accessibility

Cited by 163

Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement

Al-Adra, D. P., Hammel, L., Roberts, J., Woodle, E. S., Levine, D., Mandelbrot, D., Verna, E., Locke, J., D’Cunha, J., Farr, M., et al. (2021) · American Journal of Transplantation

Transplantation: Methods and OutcomesOrgan and Tissue Transplantation Research

Cited by 163

Importance of clarifying patients' desired role in shared decision making to match their level of engagement with their preferences

Politi, M. C., Dizon, D. S., Frosch, D. L., Kuzemchak, M. D., & Stiggelbout, A. M. (2013) · BMJ

Patient-Provider Communication in HealthcarePalliative Care and End-of-Life Issues

Cited by 132

Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement

Al-Adra, D. P., Hammel, L., Roberts, J., Woodle, E. S., Levine, D., Mandelbrot, D., Verna, E., Locke, J., D’Cunha, J., Farr, M., et al. (2021) · American Journal of Transplantation

Cutaneous Melanoma Detection and ManagementTransplantation: Methods and Outcomes

Cited by 87

AMG-232 sensitizes high MDM2-expressing tumor cells to T-cell-mediated killing

Sahin, I., Zhang, S., Navaraj, A., Zhou, L., Dizon, D., Safran, H., & El-Deiry, W. S. (2020) · Cell Death Discovery

Cancer-related Molecular PathwaysCancer Immunotherapy and Biomarkers

Cited by 66

Randomised controlled trial comparing hypnotherapy versus gabapentin for the treatment of hot flashes in breast cancer survivors: a pilot study

MacLaughlan David, S., Salzillo, S., Bowe, P., Scuncio, S., Malit, B., Raker, C., Gass, J. S., Granai, C. O., & Dizon, D. S. (2013) · BMJ Open

Menopause: Health Impacts and TreatmentsCancer survivorship and care

Cited by 37

Evaluating the use of web versus mobile devices for ePRO reporting and severe symptom responses at 6 cancer centers.

Cronin, C., Tramontano, A., Schrag, D., Wong, S. L., Osarogiagbon, R. U., Hazard-Jenkins, H. W., Dizon, D. S., Bian, J. J., & Hassett, M. J. (2022) · Journal of Clinical Oncology

Cancer survivorship and careMobile Health and mHealth Applications

Cited by 1